Vasoactive intestinal polypeptide (VIP): current status.
Research on VIP continues at a rapid pace. Recent progress includes: insights into its biosynthesis (and that of a closely related PHI-like peptide) and its neuronal localization, discovery of novel biological actions, new data on its release and binding to specific receptors, and additional evidence for its roles in physiological regulation and in the pathogenesis of disease.
D000818:Animals; D001923:Brain Chemistry; D005088:Exocrine Glands / Q000502:physiology; D005260:Female; D005836:Genitalia, Female / Q000502:physiology; D005837:Genitalia, Male / Q000502:physiology; D006321:Heart / Q000502:physiology; D006728:Hormones / Q000502:physiology; D006801:Humans; D008168:Lung / Q000502:physiology; D008297:Male; D018377:Neurotransmitter Agents / Q000502:physiology; D011956:Receptors, Cell Surface / Q000502:physiology; D018005:Receptors, Vasoactive Intestinal Peptide; D014018:Tissue Distribution; D014660:Vasoactive Intestinal Peptide / Q000502:physiology*
D006728:Hormones; D018377:Neurotransmitter Agents; D011956:Receptors, Cell Surface; D018005:Receptors, Vasoactive Intestinal Peptide; D014660:Vasoactive Intestinal Peptide